My watch list  

Japanese Encephalitis

News Japanese Encephalitis

  • Zika vaccine induces strong immune response in three phase 1 studies

    Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response. Each of the three studies included in the paper was designed to address a unique question more

  • Sanofi Pasteur signs research agreement for Zika Vaccine

    Sanofi and its vaccines global business unit Sanofi Pasteur announced today a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Research (WRAIR) on the co-development of a Zika vaccine candidate.  According to the terms of the agreement, WRAIR will transfer its Zi more

  • VABIOTECH licenses cell-based japanese encephalitis technology from Inviragen

    The Company for Vaccine and Biological Production No.1 (VABIOTECH) and Inviragen, Inc. announced a licensing agreement by which VABIOTECH will acquire rights to Inviragen’s proprietary Japanese encephalitis (JE) technology to produce a cell-derived vaccine. A cell-based JE vaccine has the potential more

All news on japanese encephalitis

Japanese Encephalitis

Japanese Encephalitis Japanese encephalitis (Japanese : 日本脳炎, Nihon-nōen; previously known as Japanese B encephalitis to distinguish it from von Economo's A encephalitis) is a disease caused by the mosquito -borne Japanese encephalitis virus ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE